Triumph Research Intelligence is asking industry leaders from Sponsors and CROs five thought-provoking questions about how COVID has changed their business. Everyone has a different story to tell and each has fascinating and valuable insights. “Accelerated acceptance for the pace of innovations, remote monitoring by necessity, EHR to EDC direct integration and accelerated telemedicine,” are just some of the ways Nick Dyer, CEO of Catalyst Clinical Research, LLC, has adapted to the “new normal.”
Tune in to hear Nick discuss this, along with his other 5 minutes 5 questions answers below.
Stay Informed with the Latest Insights
Subscribe to our newsletter and receive expert knowledge directly in your inbox. Stay ahead in the world of oncology research.
By clicking Sign Up you’re confirming that you agree with our Privacy Policy.